Clear Street’s Estrella Immunopharma, Inc. Warrant ESLAW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.61K | Buy |
33,982
+5,291
| +18% | +$251 | ﹤0.01% | 569 |
|
|
2025
Q1 | $2.21K | Buy |
28,691
+100
| +0.3% | +$8 | ﹤0.01% | 434 |
|
|
2024
Q4 | $2.63K | Hold |
28,591
| – | – | ﹤0.01% | 431 |
|
|
2024
Q3 | $1.84K | Sell |
28,591
-100
| -0.3% | -$6 | ﹤0.01% | 540 |
|
|
2024
Q2 | $1.98K | Buy |
28,691
+100
| +0.3% | +$7 | ﹤0.01% | 574 |
|
|
2024
Q1 | $1.9K | Hold |
28,591
| – | – | ﹤0.01% | 568 |
|
|
2023
Q4 | $858 | Hold |
28,591
| – | – | ﹤0.01% | 626 |
|
|
2023
Q3 | $6.87K | Sell |
28,591
-300
| -1% | -$72 | ﹤0.01% | 576 |
|
|
2023
Q2 | $1.6K | Buy |
28,891
+1,200
| +4% | +$67 | ﹤0.01% | 887 |
|
|
2023
Q1 | $2.83K | Buy |
27,691
+100
| +0.4% | +$10 | ﹤0.01% | 756 |
|
|
2022
Q4 | $1K | Buy |
27,591
+9,841
| +55% | +$357 | ﹤0.01% | 871 |
|
|
2022
Q3 | $1K | Buy |
17,750
+17,650
| +17,650% | +$994 | ﹤0.01% | 965 |
|
|
2022
Q2 | $0 | Buy |
+100
| New | – | ﹤0.01% | 995 |
|